Altar Rock’s Thermo Fisher Scientific TMO Stock Holding History

Altar Rock’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-444	Closed	-$218K	–	154
2026 Q1	$218K	Sell	444 -1	-0.2%	-$543	0.26%	115
2025 Q4	$258K	Buy	+445	New	+$252K	0.31%	75

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Altar Rock's TMO Position: Q2 2026 in Review

Altar Rock sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 444 shares — an estimated $218K sold.

Altar Rock first reported a position in TMO in Q4 2025 and held it in 2 quarters. The position peaked at $258K in Q4 2025. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Altar Rock reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
Altar Rock sold 444 Thermo Fisher Scientific shares in Q2 2026, an estimated $218K.
Altar Rock first reported a position in Thermo Fisher Scientific in Q4 2025 and held it in 2 quarters.
Altar Rock's Thermo Fisher Scientific position peaked at $258K in Q4 2025.
2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Altar Rock's 13F filing for Q2 2026, filed 21 Sep 2026.